Schools: The New Normal | New York City's Youngest Students Head Back To School, While Most Others Remain All-Remote
It was supposed to be the first day of school for all students, but another delay was announced last week.
Watch CBS News
It was supposed to be the first day of school for all students, but another delay was announced last week.
Coronavirus cases are on the rise in one part of New Jersey.
Andrew Rigie with the NYC Hospitality Alliance and New York City Councilman Justin Brannan told CBS2 they have been calling on City Hall for months to release outdoor heating guidance.
The president's claim comes two days after he criticized CDC Director Dr. Robert Redfield, who told Congress that a vaccine won't be widely available until next summer.
The mayor said the delay will help address a staffing shortage and to make sure buildings are safe, but some parents and teachers are not convinced.
The report from the mayor's office also said the number of deaths in the city skyrocketed in the last year, with more than 65,000 deaths reported in fiscal year 2020.
Most other schools in the district will remain open, except for Charles E. Walters Elementary School.
The city's blended learning model was supposed to start Sept. 10, but in-person classes were already pushed to Sept. 21.
What starts as eczema can set off a chain of events that may progress to food and pollen allergies, even asthma.
President Trump repeatedly contradicted congressional testimony from CDC Director Robert Redfield on Wednesday, casting doubt on the expert's timing for a coronavirus vaccine.
While students logged on for the first time Wednesday, educators demanded learning stay this way.
In the battle against COVID-19, some companies are getting closer to true at-home testing. It's what experts say is a critical weapon against the pandemic.
In preparing for the flu season, Stop & Shop did its market research and anticipated a 35% increase in demand for the influenza vaccine, but that projection ended up being off.
The mainly symbolic move is expected to save $860,000.
The potential drug is called AB-8, a small piece of the anti-COVID antibodies that have been used to treat COVID patients by blocking or neutralizing the coronavirus.
